- Previous Close
5.84 - Open
6.20 - Bid 6.03 x --
- Ask 6.04 x --
- Day's Range
5.80 - 6.09 - 52 Week Range
3.16 - 16.49 - Volume
24,995,944 - Avg. Volume
35,088,243 - Market Cap (intraday)
3.981B - Beta (5Y Monthly) 0.46
- PE Ratio (TTM)
-- - EPS (TTM)
-0.70 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Jun 23, 2020
- 1y Target Est
--
Xiangxue Pharmaceutical Co., Ltd. engages in the research and development, procurement, manufacture, delivery, and distribution of pharmaceutical products in China. It offers antivirotic oral liquids under the Xiangxue brand name; and healthcare supplements, as well as health solutions, such as food and beverage. Xiangxue Pharmaceutical Co., Ltd. has strategic partnership agreement with 111, Inc. to develop the Internet + Medicine model for China's traditional Chinese medicine industry. Xiangxue Pharmaceutical Co., Ltd. was founded in 1997 and is based in Guangzhou, China.
www.xphcn.comRecent News: 300147.SZ
View MorePerformance Overview: 300147.SZ
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 300147.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 300147.SZ
View MoreValuation Measures
Market Cap
3.86B
Enterprise Value
6.12B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.82
Price/Book (mrq)
2.26
Enterprise Value/Revenue
2.91
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-21.89%
Return on Assets (ttm)
-0.63%
Return on Equity (ttm)
-19.45%
Revenue (ttm)
2.1B
Net Income Avi to Common (ttm)
-460.69M
Diluted EPS (ttm)
-0.70
Balance Sheet and Cash Flow
Total Cash (mrq)
75.6M
Total Debt/Equity (mrq)
110.24%
Levered Free Cash Flow (ttm)
-380.88M